4//SEC Filing
CASI Pharmaceuticals, Inc. 4
Accession 0001144204-17-019226
CIK 0000895051operating
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:45 PM ET
Size
5.5 KB
Accession
0001144204-17-019226
Insider Transaction Report
Form 4
Zukiwski Alexander A
Chief Medical Officer
Transactions
- Award
Stock Options (Right to Buy)
2017-04-03+300,000→ 300,000 totalExercise: $1.34Exp: 2027-04-03→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 25% following 90 days from the date of grant, and the remainder ratably over three years on a monthly basis.
Documents
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000895051
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:45 PM ET
- Size
- 5.5 KB